SpyGlass Pharma Inc. Common Stock

SGP | NASDAQ

Price Alert Chart Builder DCF Calculator

$32.39

-$0.12 (-0.37%)

At close: Oct 30, 2026, 3:59 PM ET

$32.24

-$0.15 (-0.46%)

After-hours: Oct 30, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.37%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

22.8

+1.0 pts

Fundamentals Weak

Market Sentiment Neutral

Moat None

Sector Rank #963/1028 (Top 94%)

Full Analysis

Key Statistics

Market Data

Market Cap $1.08B

1D Range

31.75 32.93

52W Range

17.56 32.92

Valuation (TTM)

PE -19.51

PB 4.66

EV/EBITDA -14.56

Valuation (NTM)

Forward PE N/A

Forward PEG -0.75

Price Target $38.00

Cash Flow

FCF Yield -4.6%

SBC Adj. FCF Yield -4.8%

SBC Impact -3.7%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y N/A | N/A

FCF 3Y | 5Y N/A | N/A

Returns

ROA -23.0%

ROE -75.6%

ROIC -26.5%

Financial Health

Net Cash

$234.19M

Current Ratio 25.06

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigati...

Sector Healthcare

Industry Biotechnology

Employees 76

IPO Date Feb 6, 2026

Website www.spyglasspharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$38.00

Upside

+17.32%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞